Jiaqi Huang, Author at Ractigen Therapeutics

Company News Homepage News News Highlight

Ractigen Therapeutics Founder Dr. Long-Cheng Li Awarded 2024 Life Science Ice Breaking Award

NANTONG and SUZHOU, China, Dec. 30, 2024 — Ractigen Therapeutics proudly announces that its Founder…

Jiaqi HuangDecember 31, 2024

Company News

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS

NANTONG and SUZHOU, China, Dec. 24, 2024 — Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated…

Jiaqi HuangDecember 24, 2024

Company News

Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALS

NANTONG and SUZHOU, China, Nov. 19, 2024 — Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated…

Jiaqi HuangNovember 19, 2024

© 2025 Ractigen Therapeutics. All Rights Reserved. Privacy Policy Terms